<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Cannom, David S.</style></author><author><style face="normal" font="default" size="100%">Swerdlow, Charles D.</style></author><author><style face="normal" font="default" size="100%">Lampert, Rachel J.</style></author><author><style face="normal" font="default" size="100%">Ellenbogen, Kenneth A.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Latest Data Regarding Device Therapy for Ventricular Arrhythmias</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-07-02 10:57:42</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">26-28</style></pages><abstract><style  face="normal" font="default" size="100%">This article provides updates in the fields of device therapy for ventricular arrhythmias—including risk stratification regarding patient selection for implantable cardioverter defibrillators, the optimal programming for implantable cardioverter defibrillators to reduce inappropriate shocks, the impact of sports participation on patients with implantable cardioverter defibrillators, and the future of resynchronization therapy.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>